Article info
PDFEditorial commentary
Dopamine transporter imaging with [123I]FP-CIT (DaTSCAN) in Parkinson's disease with depressive symptoms: a biological marker for causal relationships?
- Correspondence to Dr Igor Grachev, Medical Affairs, New Product Development, GE Healthcare—Life Sciences, 101 Carnegie Center, Princeton, NJ 08540, USA; igor.grachev{at}ge.comor grachevi{at}hotmail.com
Citation
Dopamine transporter imaging with [123I]FP-CIT (DaTSCAN) in Parkinson's disease with depressive symptoms: a biological marker for causal relationships?
Publication history
- Received April 4, 2013
- Accepted April 14, 2013
- First published July 6, 2013.
Online issue publication
April 13, 2021
Article Versions
- Previous version (13 April 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions